Ofuro Group SRL
Ofuro Group reported total assets of 48,053 € at the end of the 2025 financial year (annual accounts filed with the NBB on 25 Sep 2026).
The score of Ofuro Group shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Total assets -43 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Ofuro Group's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 25 Sep 2026
- Year ended 31 Dec 2024filed on 22 Sep 2025
- Year ended 31 Dec 2023filed on 21 Nov 2024
- Year ended 31 Dec 2022filed on 28 Oct 2023
- Year ended 31 Dec 2021filed on 06 Oct 2022
Ofuro Group's financial analysis
- Solvency-154.4%sector median: 46.0%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Ofuro Group
Ofuro Group's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0463.418.884
- VAT number
- BE0463418884
- Peppol
- Registered · 0208:0463418884 · as of 11 Nov 2026
- Legal form
- SRL
- Incorporated
- 22 May 1998
- Registered office
- 1930 Zaventem
- Latest accounts
- 2025 · filed on 25 Sep 2026
- Activity
- Wholesale of pharmaceutical and medical goods (NACE 46460)
Ofuro Group (SRL) has been based in Zaventem since 1998, active in: wholesale of pharmaceutical and medical goods. For 2025, it reports a net loss of 11,195 € and equity of −74,198 €; its revenue is not published. Its solvency stands at -154.4%, below the median of its sector (46.0%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Ofuro Group
Companies in the same business, of comparable size and area, outside its group.
- Biocon Biologics Belgium Wholesale of pharmaceutical and medical goods Machelen (Brab.) · balance sheet €1.09m
- Stoma International Wholesale of pharmaceutical and medical goods Schaerbeek · balance sheet 65,737 €
- Med Inspire Wholesale of pharmaceutical and medical goods Brussels · balance sheet 18,200 €
- Endoceutics Wholesale of pharmaceutical and medical goods Brussels · balance sheet €3.45m
- BVPM Distribution Andenne · balance sheet 20,739 €
- Launchpad Europe Wholesale of pharmaceutical and medical goods Oostkamp · balance sheet 120,635 €
- Maimonides Wholesale of pharmaceutical and medical goods Antwerp · balance sheet 142 €
- Wimeq Wholesale of pharmaceutical and medical goods Heusden-Zolder · balance sheet 48,978 €
Frequently asked questions about Ofuro Group
What is the revenue of Ofuro Group?
Ofuro Group files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Ofuro Group?
In Belgium, the VAT number is the company number prefixed with BE: BE0463418884 for Ofuro Group, if the company is VAT-registered. Its company number (CBE) is 0463.418.884.
Where is the registered office of Ofuro Group?
According to the CBE register, the registered office of Ofuro Group is in 1930 Zaventem.
What is the equity of Ofuro Group?
At the close of the 2025 financial year, the equity of Ofuro Group amounts to -74,198 €, a solvency of -154.4% of total assets.
Who manages Ofuro Group?
The register lists 1 active mandates at Ofuro Group. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Ofuro Group
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →